Published in Vaccine Weekly, July 16th, 2008
"Here, we showed that in vivo VV infection results in the expansion of c-Kit(hi)Sca-1(+)Lin(-) (KSL) hematopoietic stem cells. The in vivo expansion of the KSL population requires MyD88 that is a critical adaptor for Toll-like receptor-mediated signaling. Moreover, in BM of VV-infected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly